Endoscopic ultrasound versus conventional endoscopic cyanoacrylate glue injection for the management of gastrointestinal bleeding in cirrhosis: a randomized controlled trial
Authors:
- 6 November 2025
- journal article
- research article
- Published by Springer Nature in Surgical Endoscopy
- p. 1-10
Abstract
Background & Aims Cirrhosis with unexplained upper gastrointestinal bleeding (CUUGB) remains a persistent diagnostic and therapeutic challenge in the management of patients with cirrhosis. It is worth investigating whether EUS-guided cyanoacrylate injection (EUS-CYA) provides greater efficacy in the diagnosis and treatment of CUUGB compared to cyanoacrylate injection under direct endoscopy (DEI-CYA). Methods This study enrolled 116 patients with CUUGB and employed a single-blind, prospective, parallel-group randomized design to assign participants into two arms: the DEI-CYA group (n = 58) and the EUS-CYA group (n = 58). Both groups of patients were followed up at 1, 3, and 6 months postoperatively. In cases of rebleeding during this period, endoscopy was promptly repeated. The primary outcome was the comparison of rebleeding rates between the two groups of patients with CUUGB. Secondary outcomes included technical success rate, rate of vascular obliteration, Occurrence of complications during follow-up, and liver function status. Results Among the 116 enrolled patients, direct endoscopy revealed 47 cases (40.51%) with gastric fundal red-color signs (RCS) and 27 cases (23.30%) with punctate erosions. Post-treatment, the EUS-CYA group demonstrated a significantly higher GV obliteration rate (82.76% vs. 65.52%, p = 0.035) and a lower long-term rebleeding rate (22.41% vs. 60.34%, p < 0.01) compared to the DEI-CYA group. The cumulative incidence of rebleeding was lower in the EUS-CYA group (p = 0.003). Liver function improved following EUS-CYA, with significant increases in albumin (p = 0.038) and prothrombin time (PT, p = 0.009), whereas DEI-CYA improved only PT (p = 0.002). Multivariate analysis identified diabetes mellitus as an independent predictor of rebleeding (OR = 0.19; 95% CI: 0.06–0.65; p = 0.008). Notably, DEI-CYA was associated with significantly higher odds of rebleeding compared to EUS-CYA (OR = 0.23; 95% CI: 0.10–0.56; p = 0.001). Conclusions Compared with DEI-CYA, EUS-CYA demonstrates a significantly higher detection rate of bleeding etiology, superior vascular obliteration rates, and a lower incidence of rebleeding in patients with CUUGB. Chinese Clinical Trial Registry (ChiCTR) website (https://www.chictr.org.cn/), Number ChiCTR2200058888. Graphical AbstractKeywords
This publication has 29 references indexed in Scilit:
- EUS-guided coiling plus glue injection compared with endoscopic glue injection alone in endoscopic treatment for gastric varices: a systematic review and meta-analysisGastrointestinal Endoscopy, 2024
- Application of Indian ink markers for locating gastric varices under endoscopic ultrasonographySurgical Endoscopy, 2023
- Endoscopic ultrasonography-guided injection of cyanoacrylate in the treatment of gastroesophageal varices type 1: a single-center randomized studySurgical Endoscopy, 2023
- Novel classification for adverse events in GI endoscopy: the AGREE classificationGastrointestinal Endoscopy, 2022
- Partial splenic embolization combined with endoscopic therapies and NSBB decreases the variceal rebleeding rate in cirrhosis patients with hypersplenism: a multicenter randomized controlled trialHepatology International, 2021
- The Role of Endoscopic Ultrasound (EUS) in the Management of Gastric VaricesCurrent Gastroenterology Reports, 2021
- Portal hypertensive bleeding in cirrhosisHepatology, 2017
- EUS-guided angiotherapy for gastric varices: coil, glue, and sticky issuesGastrointestinal Endoscopy, 2013
- EUS-guided transesophageal treatment of gastric fundal varices with combined coiling and cyanoacrylate glue injection (with videos)Gastrointestinal Endoscopy, 2011
- Variceal Rebleeding and Recurrence After Endoscopic Injection SclerotherapyArchives of Surgery, 2000